Adar Cyrus Poonawalla

Adar Cyrus Poonawalla

Active Director Whole-Time Director DIN 00044815
DIN 00044815 First appointment Jan 1999 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 17 active board seats
Past companies 17 historical roles
Total affiliations 34 Since Jan 1999
Shareholding value •••• Premium profile

About Adar Cyrus Poonawalla

Data last updated:

Adar Cyrus Poonawalla is a Whole-Time Director at Serum Institute Of India Private Limited (since 2008), Director at Poonawalla Fincorp Limited (since 2021) and Director at Rising Sun Holdings Pvt Ltd (since 2019), and holds 14 more current directorships. The companies operate in Pharma, Financial Services and Real Estate and Construction. The 14 current companies with reported revenue have a combined latest revenue of ₹22,543 Cr; the largest is Serum Institute Of India Private Limited at ₹10,854 Cr (FY 2025). Earlier, Adar Cyrus Poonawalla was a Director at Phinity Developers Private Limited (2018–2024) and Director at Grihum Housing Finance Limited (2021–2023) and 15 more.

DIN 00044815
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 20 Jan 1999
Oldest Company Age 52 yrs
Largest company Serum Institute Of India Private Limited · ₹10,854 Cr (FY 2025)
Combined revenue ₹22,543 Cr across 14 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Whole-Time Director01 Apr 20081984₹10,854 Cr (FY 2025)Active
Poonawalla Fincorp Limited L51504PN1978PLC209007
Director01 Jun 20211978₹6,796 Cr (FY 2026)Active
Rising Sun Holdings Pvt Ltd U67110PN1993PTC070989
Director10 Sep 20191993₹4,403 Cr (FY 2025)Active
Director30 Jun 20202020₹161 Cr (FY 2025)Active
Sovereign Pharma Private Limited U24232MH2003PTC427275
Director28 May 20032003₹142 Cr (FY 2025)Active
Director24 Sep 19991974₹85.88 Cr (FY 2019)Active
Poonawalla Finance Private Limited U65100MH1985PTC035067
Director20 Jan 19991985₹37.26 Cr (FY 2024)Active
Designated Partner15 Mar 20132013₹26.65 Cr (FY 2021)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Phinity Developers Private Limited U70100PN2017PTC171794
Director01 Sep 20182017₹74.39 Cr (FY 2025)Active
Grihum Housing Finance Limited U65922PN2004PLC208751
Director08 Jul 20212004₹1,046 Cr (FY 2024)Active
Chakan Investment Private Limited U65993PN1990PTC054851
Additional Director05 Oct 20051990₹1.66 Cr (FY 2025)Active
Director30 Jan 20082007₹2.2 Lakh (FY 2025)Active
Director08 Apr 19991994₹1.26 Cr (FY 2025)Active
Director24 Sep 19991994₹3.54 Cr (FY 2025)Active
Director30 Nov 20062003₹19.56 Cr (FY 2025)Active
Naukhal Investment Private Ltd U67120PN1991PTC059737
Director16 Jan 20071991₹7.12 Cr (FY 2025)Active
Serum International Limited U51101PN1993PLC072981
Whole-Time Director08 Apr 20051993Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Adar Cyrus Poonawalla

NameDINCompanyDesignation
Behroze Zavareh Poonawalla00044877Serum Institute Of India Private LimitedDirector
Cyrus Soli Poonawalla00044650Serum Institute Of India Private Limited , Sovereign Pharma Private Limited and 5 moreManaging Director
Kedar Shashikant Gokhale08788551Serum Institute Of India Private Limited , Serum Institute Life Sciences Private LimitedWhole-Time Director
Natasha Adar Poonawalla01264082Serum Institute Of India Private Limited , Villoo Poonawalla Racing & Breeding Private LimitedWhole-Time Director
Parag Rajendra Deshmukh03377341Serum Institute Of India Private LimitedWhole-Time Director
Prasad Suryakant Kulkarni08991838Serum Institute Of India Private Limited , Serum Institute Life Sciences Private LimitedWhole-Time Director
Satish Ramchandra Mundra00416654Serum Institute Of India Private LimitedWhole-Time Director
Sunder Lata Anand KavitkarSerum Institute Of India Private Limited , Serum Institute Life Sciences Private LimitedCompany Secretary
Sunil Gairola08893242Serum Institute Of India Private Limited , Serum Institute Life Sciences Private LimitedWhole-Time Director
Umesh Sharadrao Shaligram00212458Serum Institute Of India Private Limited , Serum Institute Life Sciences Private LimitedWhole-Time Director
Zavareh Soli Poonawalla00044760Serum Institute Of India Private LimitedDirector
Arvind Ravinder Kapil10429289Poonawalla Fincorp LimitedManaging Director
Arvind Ravinder KapilPoonawalla Fincorp LimitedCeo
Kemisha Soni06805708Poonawalla Fincorp LimitedDirector
Kewal Kundanlal Handa00056826Poonawalla Fincorp LimitedDirector
Prabhakar Ramchandra Dalal00544948Poonawalla Fincorp LimitedDirector
Rajeev Sardana06648276Poonawalla Fincorp LimitedDirector
Sanjay Kumar09466542Poonawalla Fincorp LimitedDirector
Sanjay Kumar MirankaPoonawalla Fincorp LimitedCfo
Shabnum ZamanPoonawalla Fincorp LimitedCompany Secretary
Sonal Sanjay Modi03403571Poonawalla Fincorp LimitedDirector
Sunil Madhav Samdani10301175Poonawalla Fincorp LimitedWhole-Time Director
Vikas Shyamkumar Pandey11463386Poonawalla Fincorp LimitedWhole-Time Director
Abhay Sureshkumar Bhutada03330542Rising Sun Holdings Pvt LtdDirector
Hrishikesh Sharad Ponkshe07543556Rising Sun Holdings Pvt LtdDirector

Directorship timeline

Open interactive timeline →
Sanoti Properties Llp
Poonawalla Estates Stud And Agri Farm Privae Limited
Sovereign Pharma Private Limited
Serum Institute Life Sciences Private Limited
Premium access

Shareholding and investment profile for Adar Cyrus Poonawalla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Adar Cyrus Poonawalla

Adar Cyrus Poonawalla currently holds 17 directorships: Serum Institute Of India Private Limited (Whole-Time Director, since 01 Apr 2008, revenue ₹10,854 Cr (FY 2025)); Poonawalla Fincorp Limited (Director, since 01 Jun 2021, revenue ₹6,796 Cr (FY 2026)); Rising Sun Holdings Pvt Ltd (Director, since 10 Sep 2019, revenue ₹4,403 Cr (FY 2025)); Serum Institute Life Sciences Private Limited (Director, since 30 Jun 2020, revenue ₹161 Cr (FY 2025)); Sovereign Pharma Private Limited (Director, since 28 May 2003, revenue ₹142 Cr (FY 2025)); and 12 more.

Adar Cyrus Poonawalla was first appointed on 20 Jan 1999 as Director at Poonawalla Finance Private Limited. The most recent appointment on record is 20 Jan 2025 at Poonawalla Sports And Fitness Private Limited.

The 14 current companies of Adar Cyrus Poonawalla that report revenue have a combined latest revenue of ₹22,543 Cr: Serum Institute Of India Private Limited ₹10,854 Cr (FY 2025); Poonawalla Fincorp Limited ₹6,796 Cr (FY 2026); Rising Sun Holdings Pvt Ltd ₹4,403 Cr (FY 2025); Serum Institute Life Sciences Private Limited ₹161 Cr (FY 2025); Sovereign Pharma Private Limited ₹142 Cr (FY 2025); and 9 more.

Adar Cyrus Poonawalla held 17 earlier board appointments: Phinity Developers Private Limited (Director, 01 Sep 2018 to 29 Mar 2024); Grihum Housing Finance Limited (Director, 08 Jul 2021 to 26 Jul 2023); Chakan Investment Private Limited (Additional Director, 05 Oct 2005 to 26 Jun 2018); Poonawalla Biotechnology Park Developers Private Limited (Director, 30 Jan 2008 to 04 Feb 2011); Poonawalla Racing And Breeding Private Limited (Director, 08 Apr 1999 to 21 Dec 2009); and 12 more.

The current boards of Adar Cyrus Poonawalla's companies include Behroze Zavareh Poonawalla (Serum Institute Of India Private Limited), Cyrus Soli Poonawalla (Serum Institute Of India Private Limited), Kedar Shashikant Gokhale (Serum Institute Of India Private Limited), Natasha Adar Poonawalla (Serum Institute Of India Private Limited), Parag Rajendra Deshmukh (Serum Institute Of India Private Limited), Prasad Suryakant Kulkarni (Serum Institute Of India Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available